Abstract
The proteasome is a multicatalytic protein complex whose principal task is the degradation of a large array of proteins within the cell. Its substrates include proteins involved in cell cycle regulation, tumor suppression, apoptosis, transcription, and angiogenesis, among others. This makes the inhibition of the proteasome a promising novel therapeutic approach to cancer treatment. Bortezomib (Velcade) is the first proteasome inhibitor to have shown anti-cancer activity and reached clinical trials. Preclinical and early clinical trials in both solid tumors and hematological malignancies demonstrate that bortezomib is a relatively well-tolerated and active agent, either alone or in combination with traditional chemotherapeutic drugs. Clinical trials that may help delineate the role of bortezomib in the treatment solid tumors either as single agent or in combination are ongoing.
References
Sep 9, 1994·Cell·V J PalombellaT Maniatis
Jan 1, 1996·Annual Review of Immunology·A S Baldwin
Nov 1, 1996·Science·A A Beg, D Baltimore
Nov 1, 1996·Science·C Y WangA S Baldwin
Dec 6, 1996·Science·R W KingM W Kirschner
Dec 19, 1998·The EMBO Journal·A Ciechanover
Apr 15, 1999·Nature Medicine·C Y WangA S Baldwin
Feb 16, 2000·Lancet·G Tricot
Jun 8, 2001·Annual Review of Biochemistry·C M Pickart
Jun 16, 2001·Journal of Cellular Biochemistry·S A ShahM P Callery
Feb 1, 2003·Breast Cancer Research : BCR·Stan Lipkowitz
Citations
Sep 1, 2007·Alcoholism, Clinical and Experimental Research·Terrence M DonohueNatalia A Osna
Jul 12, 2008·Investigational New Drugs·Christopher LieuLia Gore
Jan 1, 2010·Cancers·Marco Tomasetti, Lory Santarelli
Mar 11, 2005·Expert Review of Anti-infective Therapy·Patricia P Klinger, Ulrich Schubert
Nov 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael P FanucchiJoan H Schiller
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melanie B Thomas, James L Abbruzzese
Oct 26, 2005·Breast Cancer Research and Treatment·Gert G Van den EyndenKenneth L van Golen
Nov 27, 2016·Oncotarget·Mingzhi SongShouyu Wang
Jun 15, 2007·Leukemia·R Abou-MerhiA Bazarbachi
Jul 1, 2008·Annals of Hematology·Zaher K OtrockAli Bazarbachi
Aug 4, 2007·The Oncologist·Giovanni Luca CeresoliArmando Santoro
Mar 19, 2019·Oncology Letters·Ting YuanXin Wang
Jul 11, 2009·Organic & Biomolecular Chemistry·Keisuke YoshidaSatoshi Shuto
Apr 1, 2011·International Journal of Hematology·Jian HuangJie Jin
Sep 20, 2006·Oncogene·C G ConcannonJ H M Prehn
Nov 10, 2005·The Journal of Biological Chemistry·Yolanda FernándezMaría S Soengas
May 10, 2005·Expert Review of Anticancer Therapy·Herbert B Newton
Feb 20, 2007·Cancer Research·Diana C Birle, David W Hedley
Jul 19, 2005·Cancer Research·Jian-Zhong QinBrian J Nickoloff
Mar 1, 2005·Photodiagnosis and Photodynamic Therapy·Ana P CastanoMichael R Hamblin
Dec 3, 2014·Redox Biology·Terrence M Donohue, Paul G Thomes